Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Brain Res ; 1407: 90-6, 2011 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-21741032

RESUMO

We characterized the effect of acute ischemic stroke on the activation of the hypothalamic-pituitary-adrenal (HPA) axis and evaluated the role of glucocorticoids (GC) in the clinical outcome following ischemic stroke. Male spontaneous hypertensive rats underwent permanent middle cerebral artery occlusion (PMCAO) and developed a cortical infarct. At 4h post-PMCAO or sham operation, serum levels of ACTH and corticosterone (CS) were elevated 5 and 4 fold respectively as compared to controls and then returned to basal levels at 24h post surgery. In these experimental groups we found also a significant depletion of median eminence (ME)-CRH(41). In adrenalectomized (Adx) rats that underwent PMCAO the degree of motor disability and infarct volume was similar to that of intact rats. Administration of dexamethasone (Dex) to Adx-PMCAO rats significantly improved the motor disability and decreased the infarct volume. However, in sham-Adx with PMCAO, Dex had no effect on these two parameters. In rats with PMCAO or sham-PMCAO, brain production of PGE(2) was significantly increased. This effect was further enhanced in Adx-PMCAO rats and significantly inhibited by Dex. In conclusion, activation of the HPA axis following PMCAO is due to stress induced by surgery. This activation is mediated by hypothalamic CRH(41). Absence of endogenous GC or administration of Dex in naïve rats does not alter motor and pathological parameters in the acute stage following PMCAO. In contrast, administration of Dex significantly improved the outcome following cerebral ischemia in Adx rats which may be due to increased glucocorticoid receptors. Brain production of PGE(2) does not play an important role in the pathophysiology of the acute phase of cerebral ischemia.


Assuntos
Córtex Suprarrenal/fisiologia , Isquemia Encefálica/fisiopatologia , Glucocorticoides/fisiologia , Glucocorticoides/uso terapêutico , Infarto da Artéria Cerebral Média/tratamento farmacológico , Acidente Vascular Cerebral/fisiopatologia , Adrenalectomia , Hormônio Adrenocorticotrópico/sangue , Animais , Anti-Inflamatórios/uso terapêutico , Isquemia Encefálica/complicações , Corticosterona/sangue , Hormônio Liberador da Corticotropina/metabolismo , Dexametasona/uso terapêutico , Dinoprostona/metabolismo , Sistema Hipotálamo-Hipofisário/fisiologia , Hipotálamo/metabolismo , Infarto da Artéria Cerebral Média/etiologia , Infarto da Artéria Cerebral Média/fisiopatologia , Coxeadura Animal/etiologia , Coxeadura Animal/patologia , Masculino , Eminência Mediana/fisiologia , Fragmentos de Peptídeos/metabolismo , Ratos , Ratos Endogâmicos SHR , Receptores de Glucocorticoides/efeitos dos fármacos , Receptores de Glucocorticoides/fisiologia , Acidente Vascular Cerebral/etiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA